ArticleMedicine2020

The efficacy and safety of sulforaphane as an adjuvant in the treatment of bipolar depressive disorder: Study protocol for a randomized, double-blinded, placebo-controlled, parallel-group clinical trial.

Congchong Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.